Skip to main content
Clinical Trials/NCT03592810
NCT03592810
Completed
Not Applicable

Multi-center Observational Study to Assess Optimal ECMO Settings During the First Hours of Extracorporeal Cardiopulmonary Resuscitation

Erasmus Medical Center1 site in 1 country26 target enrollmentJuly 18, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Cardiopulmonary Resuscitation
Sponsor
Erasmus Medical Center
Enrollment
26
Locations
1
Primary Endpoint
CPC score 6 months
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Rationale: Veno-arterial extracorporeal membrane oxygenation (vaECMO) during cardiopulmonary resuscitation (ECPR) might improve outcome after cardiac arrest. However, it is well established that reperfusion injury of the brain can cause microvascular and endothelial dysfunction, leading to cellular necrosis and apoptosis. While performing ECPR, following the European resuscitation guidelines, it is yet unknown how to set the ECMO settings in order to minimize ischemia-reperfusion injury of the brain.

Objective: In this study, we want to elaborate on the optimal ECMO settings in the first three hours after initiation of ECPR.

Study design: Prospective, multi-centre, observational study Study population: All patients receiving ECPR in the age between 18 and 70 years, with low flow duration<60min and receiving cerebral oximetry monitoring Intervention: application of an adhesive regional oximetry sensor on the patient's forehead and withdrawal of 12 ml extra blood in all patients.

Main study parameters/endpoints: Cerebral Performance Category at 6 months. Neuron-specific enolase (NSE) will be determined from routine blood drawings.

Registry
clinicaltrials.gov
Start Date
July 18, 2018
End Date
September 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Loes Mandigers, MD

Principal Investigator

Erasmus Medical Center

Eligibility Criteria

Inclusion Criteria

  • Witnessed cardiac arrest or signs of life during CPR (such as gasping or movement)
  • Age\>18 and \< 70 years
  • Duration of low-flow \< 60 min before decision to proceed with ECPR
  • High quality CPR (defined as end-tidal carbon dioxide (CO2et) \>10 mmHg) provided for a minimum of 15 minutes without return of spontaneous circulation (ROSC)
  • Presumed cardiac cause of cardiac arrest (such as Chest pain before collapse, ventricular tachycardia/ventricular fibrillation (VT/VF) as initial rhythm or ST-elevation on ECG)
  • Cerebral oxymetry monitoring initiated during CPR preceding ECPR

Exclusion Criteria

  • Patients with a GCS\<15 before CPR.
  • Known pre-arrest cerebral performance category CPC ≥ 3
  • Presumed noncardiac cause
  • Unwitnessed collapse
  • Suspected or confirmed pregnancy
  • ROSC within 5 minutes of Advanced cardiopulmonary life support (ACLS) performed by emergency medical service (EMS) team
  • Conscious patient
  • Known bleeding diathesis or suspected or confirmed acute or recent intracranial bleeding
  • Suspected or confirmed acute stroke
  • Known severe chronic organ dysfunction or other limitations to therapy

Outcomes

Primary Outcomes

CPC score 6 months

Time Frame: 6 months

To prospectively identify parameters correlated with Cerebral Performance Category (CPC)\* ≤ 2

Secondary Outcomes

  • Glasgow coma scale (GCS) day 28(6 months)
  • 28 day mortality(6 months)
  • CPC score discharge(6 months)
  • GCS total(6 months)
  • Hospital survival(6 months)

Study Sites (1)

Loading locations...

Similar Trials